MUTUAL CONFIDENTIALITY AGREEMENTMutual Confidentiality Agreement • April 22nd, 2024 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Delaware
This Mutual Confidentiality Agreement (this “Agreement”) is made effective as of the date of the last signature below (the “Effective Date”), by and between Vertex Pharmaceuticals Incorporated, a Massachusetts corporation with offices at 50 Northern Avenue, Boston, Massachusetts 02210 (“Vertex”) and Alpine Immune Sciences, Inc., a Delaware corporation, with offices at 188 East Blaine Street, Suite 200, Seattle, WA 98102 (the “Company”). The parties contemplate discussions concerning one or more potential business arrangements involving Vertex or one or more of its Affiliates on the one hand and the Company or one or more of its Affiliates on the other hand (the “Potential Transaction”). In connection therewith, each party desires to disclose to the other party certain confidential and proprietary information for the sole purpose of enabling the receiving party to evaluate or enter into the Potential Transaction (the “Purpose”).
MUTUAL CONFIDENTIALITY AGREEMENTMutual Confidentiality Agreement • April 22nd, 2024 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations
This Mutual Confidentiality Agreement (this “Agreement”) is entered into as of March 21, 2024, by and between Vertex Pharmaceuticals Incorporated (‘‘you”) and Alpine Immune Sciences, Inc. (the “Company” and, together with you, the “parties” and, each of them, a “party”).
